알레르기 진단 및 치료제 시장 : 시장 규모, 점유율, 성장 분석, 유형별, 알레르겐 유형별, 검사 유형별, 지역별 - 산업 예측(2025-2032년)
Allergy Diagnostics and Therapeutics Market Size, Share, Growth Analysis, By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled), By Test Type, By Region - Industry Forecast 2025-2032
상품코드:1623840
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
알레르기 진단 및 치료제의 2023년 시장 규모는 306억 9,000만 달러로 평가되었고, 2024년 333억 9,000만 달러에서 2032년에는 655억 5,000만 달러로 성장할 전망이며, 예측기간 2025년부터 2032년까지의 CAGR은 8.8%로 성장할 전망입니다.
세계의 알레르기 진단 시장은 몇 가지 중요한 요인에 의해 강력한 성장이 예상되고 있습니다. 환경오염의 증가와 의료보험에 대한 접근성 향상은 이 확대에 필수적인 요인입니다. 알레르기 질환의 유병률 증가는 경제적으로 큰 영향을 주며, 알레르기 진단에 대한 투자의 고조와 맞물려 시장의 성장을 더욱 촉진하고 있습니다. 라이프 스타일의 변화, 특히 건강하지 못한 가공 식품의 섭취나 공해의 증가는, 이 동향에 큰 영향을 주고 있습니다. 또한 식품 알레르기의 급증은 종종 식생활에 대한 낮은 의식에서 발생하고 있으며, 알레르기 진단에 대한 수요의 증가를 뒷받침하고 있습니다. 모바일 헬스(mHealth) 기술의 통합과 혁신적인 치료와 고도의 진단 전략에 대한 지속적인 연구는 알레르기 진단 전망을 강화할 것을 약속하는 기술적 진보를 강화하고 큰 시장 기회를 제시합니다.
Allergy Diagnostics and Therapeutics Market size was valued at USD 30.69 Billion in 2023 and is poised to grow from USD 33.39 Billion in 2024 to USD 65.55 Billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).
The global allergy diagnostics market is poised for robust growth driven by several key factors. Rising environmental pollution and greater healthcare insurance accessibility are vital contributors to this expansion. The increasing prevalence of allergic diseases, resulting in significant economic impact, combined with heightened investment in allergy diagnostics, further propel market growth. Lifestyle changes, particularly the intake of unhealthy processed foods and rising pollution, are major influencers on this trend. Additionally, the surge in food allergies, often stemming from poor dietary awareness, underscores the growing demand for allergy diagnostics. The integration of mobile health (mHealth) technologies and continuous research into innovative treatments and advanced diagnostic strategies present substantial market opportunities, reinforcing the technological advancements that promise to enhance the allergy diagnostics landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics And Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Allergy Diagnostics And Therapeutics Market Segmental Analysis
Global Allergy Diagnostics and Therapeutics Market is segmented by type, allergen type, test type and region. Based on type, the market is segmented into diagnostics and therapeutics. Based on allergen type, the market is segmented into food, inhaled, drug and other allergens. Based on test type, the market is segmented into in vivo test and in vitro test. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Allergy Diagnostics And Therapeutics Market
The Allergy Diagnostics and Therapeutics market is significantly driven by the rising prevalence of allergic diseases, especially among urban populations who face a greater risk due to their exposure to environmental pollutants. This heightened incidence not only affects public health but also imposes a substantial economic burden on healthcare systems, as more individuals seek diagnosis and treatment for various allergy-related conditions. As cities continue to grow and pollution levels rise, the demand for effective diagnostic and therapeutic solutions in allergy management will likely increase, further propelling the growth of this market. Consequently, addressing allergies has become a vital public health concern.
Restraints in the Allergy Diagnostics And Therapeutics Market
The Allergy Diagnostics and Therapeutics market faces several constraints that may impede its growth trajectory. One significant challenge is the escalating costs associated with allergy diagnostic instruments, which can limit accessibility and affordability for healthcare providers and patients alike. Furthermore, the shortage of trained allergists may exacerbate these issues, hindering effective delivery of diagnostic services. This report delves into various aspects of the allergy diagnostics market, exploring recent developments, regulatory influences, and market dynamics, as well as identifying potential revenue opportunities and technological advancements. For further insights or assistance, please connect with Data Bridge Market Research for expert guidance.
Market Trends of the Allergy Diagnostics And Therapeutics Market
The Allergy Diagnostics and Therapeutics market is witnessing a robust upward trend, driven by the rising prevalence of allergic diseases globally. With factors such as urbanization, environmental pollution, and shifting dietary patterns contributing to the surge in allergic conditions, healthcare systems are increasingly focused on effective diagnostic methods and innovative therapeutic solutions. Advancements in technology-ranging from enhanced testing kits to targeted biologics-are improving the accuracy and efficiency of allergy management. This rising awareness and demand for personalized treatment options are propelling market growth, making it essential for stakeholders to adapt to evolving patient needs and environmental challenges in this dynamic landscape.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis
Global Allergy Diagnostics and Therapeutics Market Size by Type & CAGR (2024-2032)
Market Overview
Diagnostics
Instruments
Consumables
Services
Therapeutics
Antihistamines
Decongestants
Corticosteroids
Mast Cell Stabilizers
Leukotriene Inhibitors
Nasal Anti-Cholinergic
Immuno-Modulators
Epinephrine
Immunotherapy
Global Allergy Diagnostics and Therapeutics Market Size by Allergen Type & CAGR (2024-2032)
Market Overview
Food
Dairy Products
Poultry Product
Tree Nuts
Peanuts
Shellfish
Wheat
Soys
Other Food Allergens
Inhaled
Drug
Other Allergens
Global Allergy Diagnostics and Therapeutics Market Size by Test Type & CAGR (2024-2032)
Market Overview
In Vivo Test
Skin Prick Test
Intradermal Test
Patch Test
In Vitro Test
Global Allergy Diagnostics and Therapeutics Market Size & CAGR (2024-2032)
North America (Type, Allergen Type, Test Type)
US
Canada
Europe (Type, Allergen Type, Test Type)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Allergen Type, Test Type)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Allergen Type, Test Type)
Brazil
Rest of Latin America
Middle East & Africa (Type, Allergen Type, Test Type)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Thermo Fisher Scientific Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Siemens Healthineers (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Danaher (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Omega Diagnostics Group PLC (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
bioMerieux SA (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Romer Labs Division Holding (Austria)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
EUROIMMUN Medizinische Labordiagnostika AG (Germany)
